Literature DB >> 992646

Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis.

D S Bonikos, K G Bensch, W H NORTHWAY, D K Edwards.   

Abstract

A light and electron microscopic study was carried out in 21 infants in whom the pathologic diagnosis of bronchopulmonary dysplasia had been made. All the infants except two had the respiratory distress syndrome at birth, and all 21 had been treated with respirator and oxygen therapy for various periods of time. The pathologic alterations observed in all the infants studied were primarily damage of the bronchial and bronchiolar ciliary apparatus and mucous membranes, severe necrotizing bronchiolitis, and marked bronchiolar and alveolar fibrosis. These changes were more pronounced in infants who survived the longest period of time. Such inflammatory and fibrotic changes are known to predispose to destruction of lung tissue, emphysema, and pulmonary hypertension. Six of these 21 infants developed symptoms and signs of cardiac atrial or ventricular stress, including cor pulmonale, prior to their demise. These infants were among those that survived the longest periods of time, had the longest exposure to supplemental oxygen, and showed histopathologically severe pulmonary fibrosis and emphysema.

Entities:  

Mesh:

Year:  1976        PMID: 992646     DOI: 10.1016/s0046-8177(76)80077-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  22 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 3.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

4.  Growth of pulmonary microvasculature in ventilated preterm infants.

Authors:  Monique E De Paepe; Quanfu Mao; Jessica Powell; Sam E Rubin; Philip DeKoninck; Naomi Appel; Meredith Dixon; Füsun Gundogan
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

5.  Correlations between radiological and cytological findings in early development of bronchopulmonary dysplasia.

Authors:  G Noack; W Mortensson; B Robertson; R Nilsson
Journal:  Eur J Pediatr       Date:  1993-12       Impact factor: 3.183

Review 6.  Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology.

Authors:  Renjithkumar Kalikkot Thekkeveedu; Milenka Cuevas Guaman; Binoy Shivanna
Journal:  Respir Med       Date:  2017-10-24       Impact factor: 3.415

7.  Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats.

Authors:  S H Randell; R R Mercer; S L Young
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

8.  Effects of indomethacin on prostaglandin E2 and thromboxane B2 contents of tracheal lavage fluids in premature infants.

Authors:  J C Le Guennec; M Lauzière; R Black; P Sirois
Journal:  Inflammation       Date:  1991-02       Impact factor: 4.092

9.  Mechanisms of bronchopulmonary dysplasia.

Authors:  Antonia P Popova
Journal:  J Cell Commun Signal       Date:  2013-01-20       Impact factor: 5.782

10.  Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants.

Authors:  Monique E De Paepe; Chintan Patel; Amy Tsai; Sravanthi Gundavarapu; Quanfu Mao
Journal:  Am J Respir Crit Care Med       Date:  2008-04-17       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.